Centene Inkomsten in het verleden
Verleden criteriumcontroles 5/6
Centene is de winst gegroeid met een gemiddeld jaarlijks percentage van 17.3%, terwijl de Healthcare industrie de winst jaarlijks groeide met 5.3%. De inkomsten zijn gegroeid met een gemiddelde snelheid van 13.3% per jaar. Het rendement op eigen vermogen van Centene is 11.1%, en het heeft een nettomarge van 2.1%.
Belangrijke informatie
17.3%
Groei van de winst
14.4%
Groei van de winst per aandeel
| Healthcare Groei van de industrie | 8.5% |
| Inkomstengroei | 13.3% |
| Rendement op eigen vermogen | 11.1% |
| Nettomarge | 2.1% |
| Laatste winstupdate | 30 Sep 2024 |
Recente prestatie-updates uit het verleden
Recent updates
Centene: Should Have Followed My Original Thesis, But A Buy For Q3 2024
Oct 22Centene Corporation (NYSE:CNC) Screens Well But There Might Be A Catch
Oct 14
Should You Be Adding Centene (NYSE:CNC) To Your Watchlist Today?
Sep 26Centene (NYSE:CNC) Has Some Way To Go To Become A Multi-Bagger
Sep 08Centene (NYSE:CNC) Seems To Use Debt Quite Sensibly
Aug 20Centene Corporation: Strategic Market Position Amid Favorable Trends, Buy
Aug 20Centene (NYSE:CNC) Is Posting Promising Earnings But The Good News Doesn’t Stop There
Aug 02Here's Why We Think Centene (NYSE:CNC) Is Well Worth Watching
Jun 22A Piece Of The Puzzle Missing From Centene Corporation's (NYSE:CNC) Share Price
Jun 04Returns At Centene (NYSE:CNC) Appear To Be Weighed Down
May 14These 4 Measures Indicate That Centene (NYSE:CNC) Is Using Debt Reasonably Well
Apr 26Centene Corporation Still An Opportunity With An A-Grade Valuation
Mar 31If EPS Growth Is Important To You, Centene (NYSE:CNC) Presents An Opportunity
Mar 15Market Still Lacking Some Conviction On Centene Corporation (NYSE:CNC)
Feb 08Centene: Stay Defensive Amid Economic Uncertainty With This Low-Beta Bargain
Jan 22Is Centene (NYSE:CNC) Using Too Much Debt?
Jan 21Centene: Overlooked Healthcare Giant
Nov 21Does Centene (NYSE:CNC) Deserve A Spot On Your Watchlist?
Nov 10Centene: Solid Performance With Positive Outlook, But Limited Upside Potential
Oct 26These 4 Measures Indicate That Centene (NYSE:CNC) Is Using Debt Reasonably Well
Oct 22Decoding Centene: Why I Think It's Undervalued
Oct 10If EPS Growth Is Important To You, Centene (NYSE:CNC) Presents An Opportunity
Jul 31Centene: Results Impress But Buyers Aren't Swarming Yet
Jul 27Centene (NYSE:CNC) Has A Pretty Healthy Balance Sheet
Jul 12Centene (NYSE:CNC) Seems To Use Debt Quite Sensibly
Apr 10Centene Non-GAAP EPS of $0.86 beats by $0.02, revenue of $35.56B beats by $190M
Feb 07With EPS Growth And More, Centene (NYSE:CNC) Makes An Interesting Case
Jan 27Centene (NYSE:CNC) Seems To Use Debt Rather Sparingly
Dec 27Centene: Once Again, With Quality, Now A 'Buy'
Dec 23Centene appoints new leadership; Ken Fasola President of Centene, Dave Thomas CEO of Medicaid
Dec 14An Intrinsic Calculation For Centene Corporation (NYSE:CNC) Suggests It's 50% Undervalued
Nov 11Opbrengsten en kosten
Hoe Centene geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 30 Sep 24 | 146,204 | 3,067 | 12,507 | 0 |
| 30 Jun 24 | 144,064 | 2,823 | 12,455 | 0 |
| 31 Mar 24 | 142,800 | 2,735 | 12,573 | 0 |
| 31 Dec 23 | 141,266 | 2,702 | 12,407 | 0 |
| 30 Sep 23 | 139,364 | 2,444 | 12,130 | 0 |
| 30 Jun 23 | 138,111 | 2,713 | 11,934 | 0 |
| 31 Mar 23 | 136,941 | 1,483 | 11,704 | 0 |
| 31 Dec 22 | 135,999 | 1,202 | 11,366 | 0 |
| 30 Sep 22 | 132,756 | 2,014 | 10,892 | 0 |
| 30 Jun 22 | 129,228 | 1,860 | 10,562 | 0 |
| 31 Mar 22 | 124,181 | 1,497 | 9,888 | 0 |
| 31 Dec 21 | 118,573 | 1,347 | 9,376 | 0 |
| 30 Sep 21 | 114,130 | 736 | 9,657 | 0 |
| 30 Jun 21 | 111,284 | 720 | 9,995 | 0 |
| 31 Mar 21 | 108,158 | 2,461 | 10,461 | 0 |
| 31 Dec 20 | 104,280 | 1,808 | 10,276 | 0 |
| 30 Sep 20 | 95,764 | 2,029 | 9,529 | 0 |
| 30 Jun 20 | 86,523 | 1,556 | 8,301 | 0 |
| 31 Mar 20 | 78,105 | 845 | 7,290 | 0 |
| 31 Dec 19 | 70,807 | 1,321 | 6,448 | 0 |
| 30 Sep 19 | 68,385 | 1,353 | 6,472 | 0 |
| 30 Jun 19 | 65,507 | 1,277 | 6,591 | 0 |
| 31 Mar 19 | 61,028 | 1,082 | 6,457 | 0 |
| 31 Dec 18 | 56,688 | 900 | 6,331 | 0 |
| 30 Sep 18 | 52,618 | 889 | 5,795 | 0 |
| 30 Jun 18 | 48,655 | 1,075 | 5,105 | 0 |
| 31 Mar 18 | 47,201 | 1,029 | 4,797 | 0 |
| 31 Dec 17 | 45,810 | 828 | 4,370 | 0 |
| 30 Sep 17 | 44,870 | 853 | 4,267 | 0 |
| 30 Jun 17 | 43,646 | 796 | 4,303 | 0 |
| 31 Mar 17 | 42,468 | 713 | 4,246 | 0 |
| 31 Dec 16 | 37,693 | 562 | 3,900 | 0 |
| 30 Sep 16 | 32,839 | 416 | 3,284 | 0 |
| 30 Jun 16 | 28,062 | 360 | 2,719 | 0 |
| 31 Mar 16 | 22,948 | 277 | 2,152 | 0 |
| 31 Dec 15 | 21,292 | 356 | 1,990 | 0 |
| 30 Sep 15 | 19,854 | 350 | 1,827 | 0 |
| 30 Jun 15 | 18,548 | 339 | 1,699 | 0 |
| 31 Mar 15 | 17,102 | 298 | 1,564 | 0 |
| 31 Dec 14 | 15,689 | 268 | 1,424 | 0 |
| 30 Sep 14 | 14,134 | 210 | 1,300 | 0 |
| 30 Jun 14 | 12,700 | 179 | 1,183 | 0 |
| 31 Mar 14 | 11,475 | 172 | 1,055 | 0 |
| 31 Dec 13 | 10,544 | 161 | 931 | 0 |
Kwaliteitswinsten: CNC heeft hoge kwaliteitsinkomsten.
Groeiende winstmarge: De huidige netto winstmarges (2.1%) CNC } zijn hoger dan vorig jaar (1.8%).
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: De winst van CNC is de afgelopen 5 jaar met 17.3% per jaar gegroeid.
Versnelling van de groei: De winstgroei van CNC over het afgelopen jaar ( 25.5% ) overtreft het 5-jarig gemiddelde ( 17.3% per jaar).
Winst versus industrie: De winstgroei CNC over het afgelopen jaar ( 25.5% ) overtrof de Healthcare -sector 10.4%.
Rendement op eigen vermogen
Hoge ROE: Het Rendement op eigen vermogen ( 11.1% ) van CNC wordt als laag beschouwd.